The FDA has approved Brekiya (dihydroergotamine mesylate) injection for the acute treatment of migraine with or without aura and the acute treatment of cluster headaches in adults.

The FDA granted Priority Review to lenacapavir for the prevention of HIV as pre-exposure prophylaxis (PrEP). Lenacapavir is a long-acting HIV-1 capsid inhibitor administered as a twice-yearly ...

Drug overdose deaths in the United States decreased from an estimated 110,037 in 2023 to 80,391 in 2024. HealthDay News — Drug overdose deaths decreased by 26.9 percent from 2023 to 2024, according to ...

Gabapentinoids are not associated with risk for self-harm in adults; however, elevated risk is seen before initiation of treatment, during the initial phase of treatment, and after discontinuation of ...

HealthDay News — Preinjury mobility data predicts recovery following a lower-extremity fracture in adults, according to a proof-of-concept study published online April 28 in the Journal of Bone & ...

OpenAI has unveiled a large dataset to help test how well artificial intelligence models answer health care questions.

The executive order instructs the U.S. Department of Health and Human Services to align Medicare payments for drugs given in a doctor’s office with the lowest prices paid by other nations. Drug ...

Maternal RSV vaccination and nirsevimab were associated with a reduction in RSV hospitalization rates in infants aged 0 to 7 months during the 2024-2025 RSV season.

In a retrospective cohort study, researchers examined whether race impacts prescribing patterns for common analgesics in children following surgical procedure.

Metabolic syndrome is associated with elevated levels of pain catastrophizing among patients with PsA and may impact disease activity.

Researchers assessed the safety and efficacy of cebranopadol for moderate to severe acute pain following abdominoplasty.

Ubrogepant during the prodromal phase of migraine may alleviate common prodromal symptoms, according to study findings.